Benefits
Hashimoto's Thyroiditis Adjunct
Gärtner 2002 RCT (200 µg selenomethionine/day, 3 months, n=70) reduced anti-TPO antibody titers and improved thyroid ultrasound echogenicity in autoimmune thyroiditis patients. Subsequent CATALYST trial (2019) and other replications mixed — overt hypothyroidism prevention not clearly established. Modest evidence; ATA does not strongly endorse.
Better Absorption Than Inorganic Forms
Selenomethionine is absorbed ~19% better than sodium selenite (the inorganic form) per clinical trials. The organic methionine carrier allows incorporation into body protein pool — providing longer-term selenium retention vs rapid renal clearance of inorganic forms.
Selenium Status Improvement
Selenomethionine effectively raises plasma selenium and selenoprotein P (the body's main selenium transport protein). Useful for verified selenium deficiency, populations in low-selenium-soil regions (parts of China, Europe, New Zealand), or specific clinical contexts (HIV, dialysis).
Male Fertility Adjunct
Selenium is essential for sperm production — incorporated into sperm-specific selenoproteins. Deficiency causes infertility. Supplementation in deficient men may modestly improve semen parameters; effect in non-deficient unclear.
Selenoprotein Synthesis
Selenomethionine provides selenium for synthesis of >25 selenoproteins including glutathione peroxidases (antioxidant), thioredoxin reductases (redox regulation), and iodothyronine deiodinases (thyroid hormone metabolism — basis for thyroid effects).
Mechanism of action
Methionine Replacement in Protein Pool
Selenomethionine is incorporated into body proteins in place of methionine — non-specifically integrated based on relative methionine availability. Creates a 'selenomethionine reservoir' that releases selenium gradually as proteins are turned over. Long-term selenium status maintenance.
Selenoprotein P Synthesis
Selenium from selenomethionine is converted to selenocysteine and incorporated into selenoprotein P — the major selenium transport protein and itself a selenoprotein with antioxidant function.
Glutathione Peroxidase Function
Glutathione peroxidases (GPx 1-8) require selenium-containing selenocysteine in their active site. Major antioxidant enzyme system — neutralizes lipid peroxides and hydrogen peroxide. Selenium adequacy supports GPx activity.
Iodothyronine Deiodinase (Thyroid)
Selenium-dependent deiodinases (DIO1, DIO2, DIO3) convert thyroid hormones (T4 ↔ T3 ↔ rT3). Selenium deficiency impairs T4-to-T3 conversion — basis for thyroid autoimmunity benefits.
Clinical trials
Randomized, placebo-controlled trial of 200 µg/day selenomethionine vs placebo in 70 patients with autoimmune thyroiditis for 3 months. Outcomes: anti-TPO antibodies, thyroid ultrasound. (Gärtner et al. 2002, J Clin Endocrinol Metab)
70 Hashimoto's patients.
Selenomethionine reduced anti-TPO antibody titers by ~36% and improved thyroid ultrasound echogenicity vs placebo. Foundational trial supporting selenium for autoimmune thyroiditis. Subsequent replication trials mixed.
Clinical trials comparing absorption and selenoprotein activity from selenomethionine vs sodium selenite.
Healthy adults.
Selenomethionine ~19% better absorbed than sodium selenite. Higher and more sustained plasma selenium levels. Greater incorporation into body protein pool. Established as preferred form for repletion.
About this ingredient
Selenomethionine is the L-amino acid SELENOMETHIONINE — identical structure to methionine but with the sulfur atom replaced by SELENIUM. The ORGANIC FORM of selenium found naturally in foods (Brazil nuts, fish, meat, eggs, garlic, mushrooms) and produced commercially via selenium-fed Saccharomyces cerevisiae yeast (selenium yeast contains primarily selenomethionine). Elemental selenium content: ~40% by weight.
RDA: 55 µg/day adults.
UL: 400 µg/day.
KEY DISTINCTION FROM INORGANIC FORMS: (1) Selenomethionine is incorporated into body protein pool in place of methionine — creates long-term selenium reservoir; (2) ~19% better absorption than sodium selenite; (3) Sustained plasma selenium and selenoprotein P elevation.
EVIDENCE-BASED USES: (1) HASHIMOTO'S THYROIDITIS — Gärtner 2002 reduced anti-TPO; replication mixed; modest evidence; (2) Selenium deficiency repletion; (3) Selenium-deficient soil region populations (parts of China — Keshan disease, parts of Europe, New Zealand); (4) HIV — modest immune support evidence; (5) Male fertility adjunct in deficient men; (6) Adjunct to chemotherapy (controversial — antioxidant may reduce some agents' efficacy).
CRITICAL CAUTIONS: (1) SELENIUM TOXICITY (SELENOSIS) — chronic >800 µg/day; hair loss, brittle nails, neurological symptoms; Total Body Formula 2008 caused mass selenium poisoning from contaminated supplement; (2) SELECT TRIAL — vitamin E + selenium did NOT prevent prostate cancer; possible T2DM RISK SIGNAL at high doses in selenium-replete populations; (3) BRAZIL NUTS — eating 5+ daily can chronically exceed UL; rotation recommended; (4) PREGNANCY/LACTATION — RDA-level safe; high-dose AVOID; pregnancy RDA 60 µg/day; (5) MOST ADULTS in selenium-adequate regions (US, Canada, Japan) DO NOT NEED selenium supplementation — typical diets adequate; (6) HASHIMOTO'S — modest evidence; ATA does not strongly endorse routine use; consult endocrinologist; (7) DRUG INTERACTIONS — chemotherapy (consult oncologist), warfarin (theoretical bleeding); (8) For Hashimoto's, evidence-based management is LEVOTHYROXINE for hypothyroidism; selenomethionine adjunctive at most.